The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP48787-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K16762525 TSA202762-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 TSA202804-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 TSA202846-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 TSA202891-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 TSA202944-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 TSA202983-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K16762525 TSA203008-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 TSA203048-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 TSF430339-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 10.0 µM for 24.0 h 1 subfactor(s) TSF430340-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 3.33 µM for 24.0 h 1 subfactor(s) TSF430341-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 1.11 µM for 24.0 h 1 subfactor(s) TSF430342-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.37 µM for 24.0 h 1 subfactor(s) TSF430343-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.125 µM for 24.0 h 1 subfactor(s) TSF430344-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.04 µM for 24.0 h 1 subfactor(s) TSF531576-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 2.22 µM for 24.0 h 1 subfactor(s) TSF531577-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.74 µM for 24.0 h 1 subfactor(s) TSF531578-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.25 µM for 24.0 h 1 subfactor(s) TSF531579-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.08 µM for 24.0 h 1 subfactor(s) TSF531580-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.03 µM for 24.0 h 1 subfactor(s) TSF531581-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.01 µM for 24.0 h 1 subfactor(s) TSF430635-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 10.0 µM for 24.0 h 1 subfactor(s) TSF430636-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 3.33 µM for 24.0 h 1 subfactor(s) TSF430637-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 1.11 µM for 24.0 h 1 subfactor(s) TSF430638-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.37 µM for 24.0 h 1 subfactor(s) TSF430639-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.125 µM for 24.0 h 1 subfactor(s) TSF430640-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.04 µM for 24.0 h 1 subfactor(s) TSF531912-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 2.22 µM for 24.0 h 1 subfactor(s) TSF531913-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.74 µM for 24.0 h 1 subfactor(s) TSF531914-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.25 µM for 24.0 h 1 subfactor(s) TSF531915-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.08 µM for 24.0 h 1 subfactor(s) TSF531916-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.03 µM for 24.0 h 1 subfactor(s) TSF531917-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.01 µM for 24.0 h 1 subfactor(s) TSF430922-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 10.0 µM for 24.0 h 1 subfactor(s) TSF430923-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 3.33 µM for 24.0 h 1 subfactor(s) TSF430924-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 1.11 µM for 24.0 h 1 subfactor(s) TSF430925-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.37 µM for 24.0 h 1 subfactor(s) TSF430926-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.125 µM for 24.0 h 1 subfactor(s) TSF430927-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.04 µM for 24.0 h 1 subfactor(s) TSF532247-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 2.22 µM for 24.0 h 1 subfactor(s) TSF532248-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.74 µM for 24.0 h 1 subfactor(s) TSF532249-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.25 µM for 24.0 h 1 subfactor(s) TSF532250-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.08 µM for 24.0 h 1 subfactor(s) TSF532251-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.03 µM for 24.0 h 1 subfactor(s) TSF532252-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.01 µM for 24.0 h 1 subfactor(s) TSF431221-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 10.0 µM for 24.0 h 1 subfactor(s) TSF431222-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 3.33 µM for 24.0 h 1 subfactor(s) TSF431223-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 1.11 µM for 24.0 h 1 subfactor(s) TSF431224-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.37 µM for 24.0 h 1 subfactor(s) TSF431225-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.125 µM for 24.0 h 1 subfactor(s) TSF431226-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.04 µM for 24.0 h 1 subfactor(s) TSF431546-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 10.0 µM for 3.0 h 1 subfactor(s) TSF431547-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 3.33 µM for 3.0 h 1 subfactor(s) TSF431548-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 1.11 µM for 3.0 h 1 subfactor(s) TSF431549-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.37 µM for 3.0 h 1 subfactor(s) TSF431550-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.125 µM for 3.0 h 1 subfactor(s) TSF431551-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.04 µM for 3.0 h 1 subfactor(s) TSF532583-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 2.22 µM for 24.0 h 1 subfactor(s) TSF532584-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.74 µM for 24.0 h 1 subfactor(s) TSF532585-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.25 µM for 24.0 h 1 subfactor(s) TSF532586-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.08 µM for 24.0 h 1 subfactor(s) TSF532587-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.03 µM for 24.0 h 1 subfactor(s) TSF532588-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.01 µM for 24.0 h 1 subfactor(s) TSF532919-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 2.22 µM for 3.0 h 1 subfactor(s) TSF532920-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.74 µM for 3.0 h 1 subfactor(s) TSF532921-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.25 µM for 3.0 h 1 subfactor(s) TSF532922-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.08 µM for 3.0 h 1 subfactor(s) TSF532923-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.03 µM for 3.0 h 1 subfactor(s) TSF532924-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.01 µM for 3.0 h 1 subfactor(s) TSF431876-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 10.0 µM for 24.0 h 1 subfactor(s) TSF431877-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 3.33 µM for 24.0 h 1 subfactor(s) TSF431878-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 1.11 µM for 24.0 h 1 subfactor(s) TSF431879-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.37 µM for 24.0 h 1 subfactor(s) TSF431880-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.125 µM for 24.0 h 1 subfactor(s) TSF431881-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.04 µM for 24.0 h 1 subfactor(s) TSF533255-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 2.22 µM for 24.0 h 1 subfactor(s) TSF533256-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.74 µM for 24.0 h 1 subfactor(s) TSF533257-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.25 µM for 24.0 h 1 subfactor(s) TSF533258-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.08 µM for 24.0 h 1 subfactor(s) TSF533259-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.03 µM for 24.0 h 1 subfactor(s) TSF533260-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.01 µM for 24.0 h 1 subfactor(s) TSF432173-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K16762525 10.0 µM for 24.0 h 1 subfactor(s) TSF432174-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K16762525 3.33 µM for 24.0 h 1 subfactor(s) TSF432175-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K16762525 1.11 µM for 24.0 h 1 subfactor(s) TSF432176-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K16762525 0.37 µM for 24.0 h 1 subfactor(s) TSF432177-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K16762525 0.125 µM for 24.0 h 1 subfactor(s) TSF432178-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K16762525 0.04 µM for 24.0 h 1 subfactor(s) TSF432440-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 10.0 µM for 24.0 h 1 subfactor(s) TSF432441-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 3.33 µM for 24.0 h 1 subfactor(s) TSF432442-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 1.11 µM for 24.0 h 1 subfactor(s) TSF432443-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.37 µM for 24.0 h 1 subfactor(s) TSF432444-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.125 µM for 24.0 h 1 subfactor(s) TSF432445-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.04 µM for 24.0 h 1 subfactor(s) TSF533591-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 2.22 µM for 24.0 h 1 subfactor(s) TSF533592-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.74 µM for 24.0 h 1 subfactor(s) TSF533593-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.25 µM for 24.0 h 1 subfactor(s) TSF533594-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.08 µM for 24.0 h 1 subfactor(s) TSF533595-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.03 µM for 24.0 h 1 subfactor(s) TSF533596-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.01 µM for 24.0 h 1 subfactor(s) TSF432734-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 10.0 µM for 24.0 h 1 subfactor(s) TSF432735-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 3.33 µM for 24.0 h 1 subfactor(s) TSF432736-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 1.11 µM for 24.0 h 1 subfactor(s) TSF432737-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.37 µM for 24.0 h 1 subfactor(s) TSF432738-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.125 µM for 24.0 h 1 subfactor(s) TSF432739-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.04 µM for 24.0 h 1 subfactor(s) TSF533925-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 2.22 µM for 24.0 h 1 subfactor(s) TSF533926-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.74 µM for 24.0 h 1 subfactor(s) TSF533927-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.25 µM for 24.0 h 1 subfactor(s) TSF533928-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.08 µM for 24.0 h 1 subfactor(s) TSF533929-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.03 µM for 24.0 h 1 subfactor(s) TSF533930-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.01 µM for 24.0 h 1 subfactor(s) TSS430348-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 10.0 µM for 24.0 h TSS430349-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 3.33 µM for 24.0 h TSS430350-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 1.11 µM for 24.0 h TSS430351-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.37 µM for 24.0 h TSS430352-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.125 µM for 24.0 h TSS430353-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.04 µM for 24.0 h TSS531586-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 2.22 µM for 24.0 h TSS531587-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.74 µM for 24.0 h TSS531588-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.25 µM for 24.0 h TSS531589-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.08 µM for 24.0 h TSS531590-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.03 µM for 24.0 h TSS531591-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K16762525 0.01 µM for 24.0 h TSS430644-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 10.0 µM for 24.0 h TSS430645-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 3.33 µM for 24.0 h TSS430646-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 1.11 µM for 24.0 h TSS430647-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.37 µM for 24.0 h TSS430648-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.125 µM for 24.0 h TSS430649-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.04 µM for 24.0 h TSS531922-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 2.22 µM for 24.0 h TSS531923-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.74 µM for 24.0 h TSS531924-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.25 µM for 24.0 h TSS531925-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.08 µM for 24.0 h TSS531926-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.03 µM for 24.0 h TSS531927-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K16762525 0.01 µM for 24.0 h TSS430931-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 10.0 µM for 24.0 h TSS430932-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 3.33 µM for 24.0 h TSS430933-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 1.11 µM for 24.0 h TSS430934-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.37 µM for 24.0 h TSS430935-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.125 µM for 24.0 h TSS430936-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.04 µM for 24.0 h TSS532257-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 2.22 µM for 24.0 h TSS532258-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.74 µM for 24.0 h TSS532259-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.25 µM for 24.0 h TSS532260-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.08 µM for 24.0 h TSS532261-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.03 µM for 24.0 h TSS532262-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K16762525 0.01 µM for 24.0 h TSS431230-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 10.0 µM for 24.0 h TSS431231-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 3.33 µM for 24.0 h TSS431232-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 1.11 µM for 24.0 h TSS431233-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.37 µM for 24.0 h TSS431234-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.125 µM for 24.0 h TSS431235-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.04 µM for 24.0 h TSS431555-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 10.0 µM for 3.0 h TSS431556-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 3.33 µM for 3.0 h TSS431557-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 1.11 µM for 3.0 h TSS431558-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.37 µM for 3.0 h TSS431559-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.125 µM for 3.0 h TSS431560-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.04 µM for 3.0 h TSS532593-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 2.22 µM for 24.0 h TSS532594-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.74 µM for 24.0 h TSS532595-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.25 µM for 24.0 h TSS532596-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.08 µM for 24.0 h TSS532597-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.03 µM for 24.0 h TSS532598-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.01 µM for 24.0 h TSS532929-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 2.22 µM for 3.0 h TSS532930-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.74 µM for 3.0 h TSS532931-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.25 µM for 3.0 h TSS532932-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.08 µM for 3.0 h TSS532933-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.03 µM for 3.0 h TSS532934-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to BRD-K16762525 0.01 µM for 3.0 h TSS431885-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 10.0 µM for 24.0 h TSS431886-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 3.33 µM for 24.0 h TSS431887-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 1.11 µM for 24.0 h TSS431888-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.37 µM for 24.0 h TSS431889-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.125 µM for 24.0 h TSS431890-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.04 µM for 24.0 h TSS533265-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 2.22 µM for 24.0 h TSS533266-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.74 µM for 24.0 h TSS533267-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.25 µM for 24.0 h TSS533268-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.08 µM for 24.0 h TSS533269-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.03 µM for 24.0 h TSS533270-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K16762525 0.01 µM for 24.0 h TSS432182-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K16762525 10.0 µM for 24.0 h TSS432183-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K16762525 3.33 µM for 24.0 h TSS432184-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K16762525 1.11 µM for 24.0 h TSS432185-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K16762525 0.37 µM for 24.0 h TSS432186-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K16762525 0.125 µM for 24.0 h TSS432187-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K16762525 0.04 µM for 24.0 h TSS432449-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 10.0 µM for 24.0 h TSS432450-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 3.33 µM for 24.0 h TSS432451-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 1.11 µM for 24.0 h TSS432452-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.37 µM for 24.0 h TSS432453-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.125 µM for 24.0 h TSS432454-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.04 µM for 24.0 h TSS533601-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 2.22 µM for 24.0 h TSS533602-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.74 µM for 24.0 h TSS533603-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.25 µM for 24.0 h TSS533604-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.08 µM for 24.0 h TSS533605-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.03 µM for 24.0 h TSS533606-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K16762525 0.01 µM for 24.0 h TSS432743-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 10.0 µM for 24.0 h TSS432744-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 3.33 µM for 24.0 h TSS432745-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 1.11 µM for 24.0 h TSS432746-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.37 µM for 24.0 h TSS432747-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.125 µM for 24.0 h TSS432748-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.04 µM for 24.0 h TSS533935-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 2.22 µM for 24.0 h TSS533936-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.74 µM for 24.0 h TSS533937-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.25 µM for 24.0 h TSS533938-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.08 µM for 24.0 h TSS533939-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.03 µM for 24.0 h TSS533940-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to BRD-K16762525 0.01 µM for 24.0 h
TSP48787 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K16762525
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided